Elite Pharmaceuticals (ELTP) Long-Term Debt Repayments (2015 - 2026)
Elite Pharmaceuticals' Long-Term Debt Repayments was $96,072 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 97.6% from $4 million a year earlier.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Long-Term Debt Repayments (2015 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Long-Term Debt Repayments at Elite Pharmaceuticals came in at $4 million.
- Long-Term Debt Repayments shows a four-year compound annual growth rate of 63.7% (FY2022 to FY2026).
- In earlier fiscal years, Long-Term Debt Repayments was $336,189 in FY2025 (-4.0%), $350,171 in FY2024 (-97.1%), $12.24 million in FY2023 and $557,133 in FY2022.
- The fiscal Q1 2027 figure marks the lowest quarterly Long-Term Debt Repayments since fiscal Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Elite Pharmaceuticals | 268.12 Mn | 149.80 Mn | 13.51 Mn | 96,072.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96,072.00 |
| Mar 31, 2026 | 97,187.00 |
| Dec 31, 2025 | 96,594.00 |
| Sep 30, 2025 | 234,360.00 |
| Jun 30, 2025 | 4.09 Mn |
| Mar 31, 2025 | 90,047.00 |
| Dec 31, 2024 | 87,963.00 |
| Sep 30, 2024 | 216,850.00 |
| Jun 30, 2024 | 71,329.00 |
| Mar 31, 2024 | 350,171.00 |
| Mar 31, 2023 | 12.24 Mn |
| Mar 31, 2022 | 94,244.00 |
| Dec 31, 2021 | 462,889.00 |
| Mar 31, 2018 | 1.00 |
| Mar 31, 2017 | 10,634.00 |
| Dec 31, 2016 | -10,634.00 |
| Sep 30, 2016 | 110,982.00 |
| Jun 30, 2016 | 109,018.00 |
| Sep 30, 2015 | 119,062.00 |
| Jun 30, 2015 | 90,938.00 |
API Access
Elite Pharmaceuticals Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();